# Venous Thromboembolism in Renally Impaired Patients and Direct Oral Anticoagulants

> **NCT02664155** · PHASE3 · TERMINATED · sponsor: **Centre Hospitalier Universitaire de Saint Etienne** · enrollment: 203 (actual)

## Conditions studied

- Renal Insufficiency

## Interventions

- **DRUG:** Apixaban
- **DRUG:** Rivaroxaban
- **DRUG:** Heparin
- **DRUG:** VKA

## Key facts

- **NCT ID:** NCT02664155
- **Lead sponsor:** Centre Hospitalier Universitaire de Saint Etienne
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2016-10-19
- **Primary completion:** 2021-11-30
- **Final completion:** 2022-05-30
- **Target enrollment:** 203 (ACTUAL)
- **Why stopped:** recruiting difficulties
- **Last updated:** 2022-10-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02664155

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02664155, "Venous Thromboembolism in Renally Impaired Patients and Direct Oral Anticoagulants". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02664155. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*